Navigation Links
Inserm announces the recipients of its 2012 prizes
Date:12/4/2012

This press release is available in French.

The 2012 Inserm prizes for medical research will be awarded at a ceremony at the Collge de France on Monday 3 December 2012. This year, the grand prize will be awarded to Philippe Sansonetti in the presence of Marisol Touraine, France's Minister of Social Affairs and Health, Genevive Fioraso, France's Minister of Higher Education and Research, and Professor Andr Syrota, Chairman and CEO of Inserm. The grand prize is awarded each year to honour a member of the scientific research community whose work has contributed to advancing knowledge of human physiology, therapeutics and health in general.

Inserm Grand Prize Philippe Sansonetti

The recipient of the 2012 Grand Prize is Professor Philippe Sansonetti, the director of the Microbial Colonisation and Invasion of Mucosa unit (Inserm Unit 786) at the Institut Pasteur in Paris, in recognition of his research on microbial infection.

Prof. Sansonetti was the first to update the genetic bases in bacteria, particularly in Shigella, which causes dysentery, and which he studied the entire sequence of steps that are required for infection.

Prof. Sansonetti coordinates, along with Pascale Cossart, the Integrative Biology of Emerging Infectious Diseases laboratory of excellence.

International Prize Ingrid Grummt

The recipient of Inserm's International Prize is Professor Ingrid Grummt of the German Cancer Research Centre of Heidelberg in recognition of her epigenetics research on the molecular mechanisms that regulate gene expression.

Honour Prize Jean-Paul Soulillou

The recipient of Inserm's Honour Prize is Professor Jean-Paul Soulillou, who heads Inserm's Lymphocyte Regulation and Tolerance team at the Centre for Transplantation and Immunology Research (Inserm Unit 1064) in Nantes, France, in recognition of his work on transplant tolerance.

Prof. Soulillou is notably behind the development of a "smart" antibody that is widely used to prevent transplant rejection and his research interests include the development of highly effective immunosuppressants.

Research Prizes Sophie Ugolini and Jessica Zucman-Rossi

The Research Prizes are awarded to:

- Sophie Ugolini, an Inserm research director at the Marseille-Luminy Immunology Centre, for her work on the function of natural killer cells (NK cells).

- Jessica Zucman-Rossi, director of the Functional Genomics of Solid Tumours unit in Paris (Inserm Unit 674), for her work on the identification and understanding of the role of gene interactions in human tumours, particularly the Ewing family of tumours.

Innovation Prize Alain de Cesare and Marc Lopez

The Innovation Prizes are awarded to two engineers in recognition of their support in guiding research:

- Alain de Cesare, an Inserm research engineer at the Functional Imaging Laboratory (Inserm Unit 678) in Paris and a designer of medical imaging analysis software.

- Marc Lopez, an Inserm research engineer at the Marseille Oncology Research Centre (Inserm Unit 1068) who identified the cellular adhesion molecules known as nectins.


'/>"/>
Contact: Inserm press office
presse@inserm.fr
INSERM (Institut national de la sant et de la recherche mdicale)
Source:Eurekalert

Related medicine news :

1. EPSRC announces new green engineering projects
2. hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces Faster Weight Loss than a "No-Diet" Weight Loss Diet
3. Gabrielles Angel Foundation for Cancer Research announces 2 collaborative research grants
4. Feinstein announces submission of new drug application for diagnosing parkinsonian syndromes
5. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
6. Plastic and Reconstructive Surgery Journal announces global expansion initiatives
7. NY-Presbyterian Hospital announces participation in trial for hard-to-treat hypertension
8. Northeasterns Barnett Institute announces formation of leading analytics company, BioAnalytix, LLC
9. JDRF announces winners of first phase of Agnes Varis Glucose-Responsive Insulin Challenge
10. CRF announces late breaking trials and first report investigations to be presented at TCT 2012
11. SfN announces winners of brain awareness video contest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... The Dianne Michael Insurance ... Cincinnati metropolitan area, is teaming up with the local chapter of the Ronald ... treatment in nearby hospitals. , Ronald McDonald House of Greater Cincinnati, one of ...
(Date:6/27/2017)... ... June 27, 2017 , ... Harbour , a DAO (decentralized ... the Ethereum blockchain, has released their technical specifications . , 2017 has seen ... little systematic approach for determining which offerings will garner the greatest ROI. Dean Eigenmann, ...
(Date:6/27/2017)... ... June 27, 2017 , ... From June 20-22, EarQ and Widex ... Syracuse, New York, where EarQ is headquartered. , Together, the organizations educate hearing ... today’s savvy consumer, and the latest in hearing technology. At the event, EarQ ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... contribute to an upcoming case studies guidebook. This guidebook offers an excellent branding ... book will include articles, case studies and how-to’s that fall into the following ...
(Date:6/27/2017)... ... June 27, 2017 , ... Hammer Strength, the world’s leading ... named Javair Gillett of the Houston Rockets the NBSCA Strength & Conditioning Coach of ... decided by NBSCA members who vote to select the coach who embodies the highest ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... , June 9, 2017 More than 400 ... effort to help spread lessons learned from clinical research ... Diabetes Federation (IDF) and Eli Lilly and Company (NYSE: ... second phase of the Bringing Research in Diabetes to ... commitment to helping people with diabetes effectively manage their ...
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... of two Phase 2 trials of its RSV F protein ... child bearing age have been published in the journal ... have been shared in prior scientific conferences). The Company previously ... April 2014. Novavax is developing the RSV F Vaccine with ...
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq: ... care, today announced new findings demonstrating positive biochemical outcomes ... System One™. The data will be presented at ... Madrid, Spain . ... Improve Home Dialysis Network in Europe ...
Breaking Medicine Technology: